Faulty signaling in brain increases craving for sugar and drugs
August 30, 2011 in Neuroscience
When glutamate and dopamine do not collaborate as they should in the brain's signal system, the kick that alcohol, sugar, or other drugs induce increases. This is shown in a new Swedish-Canadian study on mice being published today in the prestigious Journal of Neuroscience. It provides a key piece of the puzzle about the mechanisms behind both substance abuse and obesity.
"Our data indicate that the brain becomes hypersensitive to rewards when this co-signaling of glutamate and dopamine does not function. Lower doses than normal are enough to increase the propensity to ingest the substance, and this is true of both sugar and cocaine," says Asa Mackenzie, associate professor of neuroscience at Uppsala University and the researcher who led the study.
Addiction disorders are a major social problem, and we lack sufficient knowledge of how they arise and how various substances impact the brain. The brain's reward system gives us feelings of pleasure and happiness, for example when we have eaten or drunk something good, had sex, or worked out. This pleasure arises when certain signal substances, primarily dopamine, are released in the brain. But this reward system can be "kidnapped" by other rewarding substances, such as alcohol and abuser drugs like cocaine. They provide feelings of reward initially, but they are so strong that nerve cells in the system are rewired, and addiction occurs. More natural substance, such as food rich in sugar, can also produce addiction-like conditions.
The Uppsala researchers and their colleagues have recently shown that dopamine cells in the reward system can send signals in cooperation with glutamate, so called co-signaling. Its physiological role was not previously known, however. For instance, how important is it for the inclination to ingest reward substances?
In studies of mice that lack the ability to send the above signals because their glutamate transporter, so-called VGLUT, has been inactivated, the scientists studied how prone the mice were to ingest sugar and cocaine. The results showed that they both ingested more and responded to lower dosages than control mice.
Since there is a strong correlation between memory and consumption substances, and ultimately also for the risk of addiction, the researchers also looked into this. They are able to present the interesting finding from the study that mice that lack the ability to co-signal developed dramatically improved memory of environments that could be associated with the ingestion of drugs. They also found changes in genetic expressions in the reward system that indicate that the brain has become hypersensitive and that dopamine levels have dropped.
"This is extremely interesting, but more research is needed in order to understand how this can be used in drug development, for instance," says Asa Mackenzie.
These scientists have now gone on to study these mechanisms in connection with abuse in humans and are looking for direct connections between low VGLUT levels and addiction.
Provided by
Uppsala University
-
Glutamate can play key role in drug impact on brain
Dec 16, 2009 |
not rated yet |
0
-
Reward-stress link points to new targets for treating addiction
Dec 16, 2008 |
not rated yet |
0
-
Why the craving for cocaine won't go away
Sep 16, 2010 |
not rated yet |
0
-
Receptor limits the rewarding effects of food and cocaine
Jul 12, 2011 |
not rated yet |
0
-
Cocaine's effects on brain metabolism may contribute to abuse
Feb 18, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
14 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Neuroscience
4 hours ago |
5 / 5 (3) |
0
|
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Neuroscience
7 hours ago |
4.8 / 5 (6) |
0
|
Waiting for a sign? Researchers find potential brain 'switch' for new behavior
You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...
Neuroscience
8 hours ago |
5 / 5 (1) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
Neuroscience
9 hours ago |
4 / 5 (4) |
0
|
Study shows where scene context happens in our brain
In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...
Neuroscience
11 hours ago |
4 / 5 (1) |
0
|
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
Biomarkers discovered for inflammatory bowel disease
Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...